Beta Bionics (BBNX) Revenue (2024 - 2026)

Beta Bionics has disclosed Revenue across 3 years of filings, most recently posting $27.6 million for Q1 2026.

• Revenue for Q1 2026 came in at $27.6 million, up 56.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.2 million (up 57.87% YoY), and the FY2025 annual result was $100.3 million, up 53.94% from the prior year.
• Revenue came in at $27.6 million for Q1 2026 at Beta Bionics, down from $32.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $32.1 million in Q4 2025 to a low of $12.9 million in Q1 2024.
• The 3-year median for Revenue is $20.4 million (2024), against an average of $21.4 million.
• Peak annual rise in Revenue reached 63.14% in 2025, while the deepest fall reached 36.39% in 2025.
• Beta Bionics' Revenue stood at $20.4 million in 2024, then soared by 57.15% to $32.1 million in 2025, then decreased by 13.99% to $27.6 million in 2026.
• The last three Revenue figures came in at $27.6 million (Q1 2026), $32.1 million (Q4 2025), and $27.3 million (Q3 2025), per Business Quant data.